While costs and other challenges are likely to remain a concern, specialty drugs continue to be researched for these and other conditions and may provide relief that traditional therapies cannot, which could potentially result in better quality of life as well as fewer hospital admissions, emergency room visits and laboratory tests. Credit: Bigstock
In workers' comp pharmacy management, opioids often get the lion's share of attention, and for good reason. As a nation, we're still challenged to ensure safe and effective application of prescriptions amid an opioid epidemic. But numbers are moving in the right direction. While opioids continue to be the most-utilized therapeutic class among our injured workers in 2022, there were declines in both utilization (7.7%) and cost (14.7%) per claim, and there's been a steady decline for the past eight years in the morphine equivalent dose (MED) prescribed to patients.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
